| Product Code: ETC6748481 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Neuroblastoma Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Neuroblastoma Market Revenues & Volume, 2021 & 2031F |
3.3 China Neuroblastoma Market - Industry Life Cycle |
3.4 China Neuroblastoma Market - Porter's Five Forces |
3.5 China Neuroblastoma Market Revenues & Volume Share, By Diagnostics, 2021 & 2031F |
3.6 China Neuroblastoma Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 China Neuroblastoma Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 China Neuroblastoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neuroblastoma cases in China |
4.2.2 Growing investments in healthcare infrastructure and research development |
4.2.3 Rising awareness about early diagnosis and treatment options for neuroblastoma |
4.3 Market Restraints |
4.3.1 High treatment costs associated with neuroblastoma therapies |
4.3.2 Limited availability of advanced treatment options in certain regions of China |
4.3.3 Stringent regulatory requirements for approval of new neuroblastoma treatments |
5 China Neuroblastoma Market Trends |
6 China Neuroblastoma Market, By Types |
6.1 China Neuroblastoma Market, By Diagnostics |
6.1.1 Overview and Analysis |
6.1.2 China Neuroblastoma Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.3 China Neuroblastoma Market Revenues & Volume, By MIBG scan, 2021- 2031F |
6.1.4 China Neuroblastoma Market Revenues & Volume, By Imaging, 2021- 2031F |
6.1.5 China Neuroblastoma Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.2 China Neuroblastoma Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 China Neuroblastoma Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.3 China Neuroblastoma Market Revenues & Volume, By Medications, 2021- 2031F |
6.2.4 China Neuroblastoma Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.5 China Neuroblastoma Market Revenues & Volume, By Radiation therapy, 2021- 2031F |
6.2.6 China Neuroblastoma Market Revenues & Volume, By Stem cell transplant, 2021- 2031F |
6.2.7 China Neuroblastoma Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.3 China Neuroblastoma Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 China Neuroblastoma Market Revenues & Volume, By Hospitals and clinics, 2021- 2031F |
6.3.3 China Neuroblastoma Market Revenues & Volume, By Ambulatory surgical centers, 2021- 2031F |
6.3.4 China Neuroblastoma Market Revenues & Volume, By Diagnostic centers, 2021- 2031F |
6.3.5 China Neuroblastoma Market Revenues & Volume, By Research centers, 2021- 2031F |
6.3.6 China Neuroblastoma Market Revenues & Volume, By Others, 2021- 2031F |
7 China Neuroblastoma Market Import-Export Trade Statistics |
7.1 China Neuroblastoma Market Export to Major Countries |
7.2 China Neuroblastoma Market Imports from Major Countries |
8 China Neuroblastoma Market Key Performance Indicators |
8.1 Survival rates of neuroblastoma patients in China |
8.2 Number of clinical trials conducted for neuroblastoma treatments in China |
8.3 Adoption rate of innovative treatment technologies for neuroblastoma in China |
9 China Neuroblastoma Market - Opportunity Assessment |
9.1 China Neuroblastoma Market Opportunity Assessment, By Diagnostics, 2021 & 2031F |
9.2 China Neuroblastoma Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 China Neuroblastoma Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 China Neuroblastoma Market - Competitive Landscape |
10.1 China Neuroblastoma Market Revenue Share, By Companies, 2024 |
10.2 China Neuroblastoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here